Diffuse lymphoma of primary cutaneous large B-cell. Case report

Authors

Keywords:

B-cell lymphoma, diffuse large B-cell lymphoma, rituximab

Abstract

Introduction: primary cutaneous B-cell lymphoma is a rare neoplastic proliferation of immunophenotype B lymphocytes; its pathogenic mechanisms are unknown.
Patient information: a 77-year-old male patient is presented, who approximately three months ago started with erythematous-violaceous, infiltrated, multifocal plaques, located on the posterior trunk, in addition to a violaceous tumor, with neoformation vessels on its surface, which was accompanied by weight loss. He was evaluated multidisciplinary and after biopsy of the lesion and staging studies it was concluded asDiffuse lymphoma of primary cutaneous large B-cell. Polychemotherapy with cyclophosphamide, doxorubicin, vincristine and prednisone and monoclonal antibody: rituximab was indicated as treatment, with favorable evolution.
Conclusions: this disease, even being unfrequent, with a good prognosis and relatively easy therapeutic management, should be suspected and diagnosed in time; the connotations that its diagnosis and treatment imply for the patient should not be forgotten.

Downloads

Download data is not yet available.

Author Biographies

Mabel González Escudero, Hospital Provincial General Universitario "Mártires del 9 de Abril"

Especialista en I y II Grado en Dermatología. Profesora Asistente en la Universidad de Ciencias Médicas de Villa Clara. Investigadora Agregada.

Sergio Morales Piñeiro, Hospital Provincial General Universitario "Mártires del 9 de Abril"

Especialista en I y II Grado en Ortopedia y Traumatología. Profesor Auxiliar en la Universidad de Ciencias Médicas de Villa Clara.

Hanuarys Lázaro Sosa Estebanez, Hospital Provincial General Universitario "Mártires del 9 de Abril"

Especialista en I Grado en Cirugía General

References

1. Barragán Estudillo ZF, Pulido Díaz N, Quintal Ramírez MJ, López Ibarr MM. Linfoma cutáneo primario de células grandes B: informe de un caso. Dermatol Cosmet Med Quir [Internet]. 2013 [citado 20/04/2020];11(3):213-216. Disponible en: https://www.medigraphic.com/pdfs/cosmetica/dcm-2013/dcm133i.pdf

2. Richards T, Boccalatte LA, Gómez NL, Nasiff MG. Linfoma primario difuso de células B grandes de mucosa gingival, en paciente VIH y EBV negativos. Rev Hosp Ital B Aires [Internet]. 2017 [citado 20/04/2020];37(4):146-148. Disponible en: https://www1.hospitalitaliano.org.ar/multimedia/archivos/noticias_attachs/47/documentos/39149_146-148-HI4-3-Richards-B.pdf

3. Peñate Y, Servitje O, Machan S, Fernández-de-Misa R, Estrach MT, Acebo E, et al. Registro de linfomas cutáneos primarios de la AEDV: primer año de funcionamiento. Actas Dermosifiliogr [Internet]. 2018 [citado 20/04/2020];109(7):610-616. Disponible en: https://www.actasdermo.org/es-pdf-S0001731018301364. https://doi.org/10.1016/j.ad.2018.03.006

4. Morales C, Damiano S, Bertini D, De Boni D. Linfoma cutáneo primario difuso de células B grandes tipo pierna: primer reporte de presentación como úlcera de Marjolin sobre úlcera venosa crónica. Rev Méd Urug [Internet]. 2015 [citado 20/04/2020];31(1):58-63. Disponible en: http://www.scielo.edu.uy/pdf/rmu/v31n1/v31n1a09.pdf

5. Chen ST, Barnes J, Duncan L. Primary cutaneous B-cell lymphomas- clinical and histopathologic features, differential diagnosis, and treatment. Semin Cutan Med Surg [Internet]. 2018 [citado 21/04/2020];37(1):49-55. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29719020/. https://doi.org/10.12788/j.sder.2018.014

6. Mengana Medina M, Fuentes Liens EE, Parra Mengana PG. Linfoma cutáneo primario de células B. Presentación de un caso. Multimed [Internet]. 2020 [citado 01/02/2021];24(6):1377-1386. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1028-48182020000601377

7. Caravaca-García A, Elhendi-Halawa W, Caravaca-Gámez C, Vázquez-Muñoz IM. Úlcera de paladar como forma de manifestación de un linfoma difuso de células B grandes. An Orl Mex [Internet]. 2017 [citado 20/4/2020];62(1):65-70. Disponible en: https://www.medigraphic.com/pdfs/anaotomex/aom-2017/aom171h.pdf

8. Pineda S, Araya I, Morales C. Linfoma cutáneo primario de células B centrofolicular: un desafío diagnóstico. Rev Chil Dermatol [Internet]. 2016 [citado 01/02/2021];32(2):26-29. Disponible en: https://rcderm.org/index.php/rcderm/article/view/100. http://dx.doi.org/10.31879/rcderm.v32i2.100

9. Pérez-Zúñiga JM, Aguilar-Andrade C, Álvarez-Vera JL, Augusto-Pacheco M, Báez-Islas PE, Bates-Martín RA, et al. Linfomas no Hodgkin de estirpe B. Rev Hematol Méx [Internet]. 2018 [citado 20/04/2020];19(4):189-214. Disponible en: https://revistadehematologia.org.mx/article/linfomas-no-hodgkin-de-estirpe-b/

10. Areán C, Córdoba A, García J, Larumbe A. Transformation of a primary cutaneous marginal zone lymphoma into a cutaneous diffuse large B-cell lymphoma. Piel [Internet]. 2017 [citado 20/04/2020];32(5):314-316. Disponible en: https://www.sciencedirect.com/science/article/pii/S0213925116303422. http://dx.doi.org/10.1016/j.piel.2016.11.009

11. Zerga ME. Linfoma difuso de células grandes B de mal pronóstico. Desarrollo de nuevas modalidades terapéuticas. Hematología [Internet]. 2015 [citado 20/04/2020];19(Número Extraordinario):183-193. Disponible en: http://www.sah.org.ar/revista/numeros/26-vol%2019-extraordinario.pdf

12. Faúndez E, de la Fuente R, Morales C, Valbuena J. Linfoma cutáneo primario de células B de la zona marginal. Rev Chilena Dermatol [Internet]. 2015 [citado 20/04/2020];31(4):395-398. Disponible en: https://www.rcderm.org/index.php/rcderm/article/view/19/19

13. Velásquez CA, González M, Berrouet MC, Jaramillo N. Cardiotoxicidad inducida por la quimioterapia desde las bases moleculares hasta la perspectiva clínica. Rev Colomb Cardiol [Internet]. 2016 [citado 20/04/2020];23(2):104-111. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-56332016000200006. https://doi.org/10.1016/j.rccar.2015.10.002

14. Pedraza-Rodríguez EM, González-Velázquez VE, Rodríguez-Rodríguez LL. Factores asociados a la cardiotoxicidad inducida por antraciclinas en pacientes con cáncer de mama. Univ Méd Pinareña [Internet]. 2020 [citado 20/04/2020];16(1):e383. Disponiben: http://www.revgaleno.sld.cu/index.php/ump/article/view/383

Downloads

Published

2022-04-04

How to Cite

1.
González Escudero M, Morales Piñeiro S, Sosa Estebanez HL. Diffuse lymphoma of primary cutaneous large B-cell. Case report. Acta Méd Centro [Internet]. 2022 Apr. 4 [cited 2025 Jul. 1];16(2):366-73. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/1623

Issue

Vol. 16 No. 2 (2022): April-June

Section

Case Reports

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).